Freitas Fernanda Moreira de, Zamoner Welder, Garms Durval Sampaio de Souza, Oliveira Mariele Gobo de, Balbi André Luis, Ponce Daniela
UNESP.
J Bras Nefrol. 2017 Jul-Sep;39(3):323-328. doi: 10.5935/0101-2800.20170055.
Sepsis is the most common cause of death in critically ill patients and it may be associated with multiorgan failure, including acute kidney injury (AKI). This situation can require acute renal support and increase mortality. Therefore, it is essential to administrate antimicrobials in dosis to achieve adequate serum levels, preventing overdosis and drug toxicity or underdosing and risk for resistance to antibiotics and higher mortality. To date, there aren't validated guidelines on antibiotic dosis adjustment in septic patients with AKI and the recommendations are extrapolated from studies conducted in non-critical patients with chronic kidney disease in end stage receiving chronic renal replacement therapy. This study aimed to review and discuss the complexity of that issue, considering the several factors related to the drugs removal: critically ill patient characteristics, antimicrobial properties and dialysis method.
脓毒症是重症患者最常见的死亡原因,可能与多器官功能衰竭有关,包括急性肾损伤(AKI)。这种情况可能需要急性肾脏支持并增加死亡率。因此,必须给予适当剂量的抗菌药物以达到足够的血清水平,防止用药过量和药物毒性,或用药不足以及产生抗生素耐药性和更高死亡率的风险。迄今为止,尚无关于脓毒症合并急性肾损伤患者抗生素剂量调整的有效指南,相关建议是从接受慢性肾脏替代治疗的终末期慢性肾病非重症患者的研究中推断出来的。本研究旨在回顾和讨论该问题的复杂性,考虑与药物清除相关的若干因素:重症患者特征、抗菌药物特性和透析方法。